Achieve Life Sciences Stock Alpha and Beta Analysis
| ACHV Stock | USD 5.15 0.18 3.62% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Achieve Life Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Achieve Life over a specified time horizon. Remember, high Achieve Life's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Achieve Life's market risk premium analysis include:
Beta 3.67 | Alpha 0.66 | Risk 6.52 | Sharpe Ratio 0.13 | Expected Return 0.83 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Achieve Life Backtesting, Achieve Life Valuation, Achieve Life Correlation, Achieve Life Hype Analysis, Achieve Life Volatility, Achieve Life History and analyze Achieve Life Performance. Achieve Life Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Achieve Life market risk premium is the additional return an investor will receive from holding Achieve Life long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Achieve Life. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Achieve Life's performance over market.| α | 0.66 | β | 3.67 |
Achieve Life expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Achieve Life's Buy-and-hold return. Our buy-and-hold chart shows how Achieve Life performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Achieve Life Market Price Analysis
Market price analysis indicators help investors to evaluate how Achieve Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Achieve Life shares will generate the highest return on investment. By understating and applying Achieve Life stock market price indicators, traders can identify Achieve Life position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Simple Moving Average | ||
| Parabolic SAR | ||
| Stalled Pattern | ||
| Separating Lines |
Achieve Life Return and Market Media
The median price of Achieve Life for the period between Tue, Oct 7, 2025 and Mon, Jan 5, 2026 is 4.58 with a coefficient of variation of 14.86. The daily time series for the period is distributed with a sample standard deviation of 0.65, arithmetic mean of 4.35, and mean deviation of 0.51. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Recent uptick might appease Achieve Life Sciences, Inc. institutional owners after losing 33 percent over the past year | 10/09/2025 |
2 | Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 6, 2025 | 10/29/2025 |
3 | ACHV FDAs CNPV Awarded for Vaping | 11/10/2025 |
4 | Real time pattern detection on Achieve Life Sciences Inc. stock - Market Trend Review Reliable Entry Point Alerts - newser.com | 11/13/2025 |
5 | Is Achieve Life Sciences Inc. stock included in top ETFs - 2025 Price Momentum AI Based Trade Execution Alerts - newser.com | 11/17/2025 |
6 | What earnings margins imply for Achieve Life Sciences Inc. stock - newser.com | 11/20/2025 |
7 | FDA Accepts Achieve Life Sciences, Inc. NDA Application for Cytisinicline in Smoking Cessation | 11/25/2025 |
8 | Acquisition by Erik Atkisson of 250000 shares of Achieve Life at 4.78 subject to Rule 16b-3 | 12/04/2025 |
9 | Stonepine Capital Management LLC Takes Position in Achieve Life Sciences, Inc. ACHV - MarketBeat | 12/05/2025 |
10 | Achieve Life Sciences to Host Meetings During the J.P. Morgan He - GuruFocus | 12/17/2025 |
11 | Achieve Life Sciences Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook - Stocktwits | 12/29/2025 |
About Achieve Life Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Achieve or other stocks. Alpha measures the amount that position in Achieve Life Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Interest Debt Per Share | 0.44 | 0.41 | Revenue Per Share | 427.63 | 406.25 |
Achieve Life Upcoming Company Events
As portrayed in its financial statements, the presentation of Achieve Life's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Achieve Life's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Achieve Life's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Achieve Life. Please utilize our Beneish M Score to check the likelihood of Achieve Life's management manipulating its earnings.
| 21st of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 21st of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Achieve Life
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Achieve Stock Analysis
When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.